Sep 06, 2024 19:52
VTGN - Vistagen Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 4.43 0.14 (3.16%) | 0.0 (0.0%) | 0.02 (0.33%) | 0.04 (0.88%) | 0.16 (3.61%) | 0.1 (2.24%) | -0.11 (-2.45%) | 0.1 (2.23%) |
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.47
- Diluted EPS:
- -0.47
- Basic P/E:
- -9.7234
- Diluted P/E:
- -9.7234
- RSI(14) 1m:
- 73.33
- VWAP:
- 4.57
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Feb 21, 2024 14:55
Feb 01, 2024 10:16
Dec 29, 2023 13:40
Dec 04, 2023 19:39
Nov 14, 2023 19:08
Oct 17, 2023 12:12
Oct 02, 2023 17:00
Aug 11, 2023 14:34
Aug 10, 2023 17:17